Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02599779
Title A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications
Therapies
Age Groups: adult
Covered Countries CAN


No variant requirements are available.